Upstream Bio (UPB) Equity Average: 2023-2025
Historic Equity Average for Upstream Bio (UPB) over the last 2 years, with Sep 2025 value amounting to $393.7 million.
- Upstream Bio's Equity Average rose 356.53% to $393.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $393.7 million, marking a year-over-year increase of 356.53%. This contributed to the annual value of $173.4 million for FY2024, which is N/A change from last year.
- Upstream Bio's Equity Average amounted to $393.7 million in Q3 2025, which was down 7.85% from $427.2 million recorded in Q2 2025.
- Upstream Bio's 5-year Equity Average high stood at $457.7 million for Q1 2025, and its period low was -$153.5 million during Q3 2024.
- Over the past 3 years, Upstream Bio's median Equity Average value was $18.6 million (recorded in 2023), while the average stood at $111.7 million.
- Data for Upstream Bio's Equity Average shows a peak YoY surged of 456.86% (in 2025) over the last 5 years.
- Quarterly analysis of 3 years shows Upstream Bio's Equity Average stood at -$117.7 million in 2023, then surged by 231.53% to $154.8 million in 2024, then surged by 356.53% to $393.7 million in 2025.
- Its Equity Average was $393.7 million in Q3 2025, compared to $427.2 million in Q2 2025 and $457.7 million in Q1 2025.